Professor in Nursing with a combined position as an oncology nurse at Cancercentrum, NUS.
Hey! My name is Per, and I am a professor at the Department of Nursing. I also have joint employment at Cancercentrum, Norrland University Hospital, Umeå. My background in healthcare is as an oncology nurse in radiation therapy.
I:
• teaches several of the department's programs/courses, preferably on oncological nursing but also in radiography and quantitative methods
• Research, among other things, on quality of life and treatment-related side effects during oncological treatment.
My clinical experience as a nurse includes oncological care and, above all, radiation therapy. My thesis was about quality of life and side effects in patients who received radiation therapy for prostate cancer. I got my PhD in November 2000 and then continued with mainly quantitative research in oncology. In 2022, I was appointed Professor in Oncology Nursing.
Areas of education:
Oncology at the graduate level, radiography, patient process during cancer care.
Areas of research:
PCSS, prospective side-effects and quality of life study in men treated for prostate cancer. SPCG7/SFUO3, prospective RCT study on quality of life for endocrine or combined treatment, endocrine + radiotherapy in men with prostate cancer. HYPO-side effects, prospective RCT study on quality of life in men treated with conventional radiotherapy vs extreme hypofractionated radiotherapy. PROCORT-Cost-effectiveness of new extreme hypofractionated radiotherapy technique compared to conventional radiotherapy for prostate cancer. PROCEED, a study on men's experiences of life-prolonging treatment for metastatic prostate cancer that is no longer responsive to hormone therapy. PROTON CARE examines patient-reported toxicity and quality of life in patients with cancer who underwent proton therapy. NPCR-side-effects, National Prostate Cancer Register of Sweden, monitoring toxicity in men treated with surgery or radiotherapy. Ultrasound-based shear wave elastography- a non-invasive method when staging the degree of liver fibrosis.